Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.
The contraction of gallbladders (GBs) with cholesterol stones is impaired due to high cholesterol concentrations in caveolae compared with GBs with pigment stones. The reduced contraction is caused by a lower cholecystokinin (CCK)-8 binding to CCK-1 receptors (CCK-1R) due to caveolar sequestration of receptors. We aimed to examine the mechanism of cholesterol-induced sequestration of receptors. Muscle cells from human and guinea pig GBs were studied. Antibodies were used to examine CCK-1R, antigens of early and recycling endosomes, and total (CAV-3) and phosphorylated caveolar-3 protein (pCAV-3) by Western blots. Contraction was measured in muscle cells transfected with CAV3 mRNA or clathrin heavy-chain small-interfering RNA (siRNA). CCK-1R returned back to the bulk plasma membrane (PM) 30 min after CCK-8 recycled by endosomes, peaking at 5 min in early endosomes and at 20 min in recycling endosomes. Pretreatment with cholesterol-rich liposomes inhibited the transfer of CCK-1R and of CAV-3 in the endosomes by blocking CAV-3 phosphorylation. 4-Amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (inhibitor of tyrosine kinase) reproduced these effects by blocking pCAV-3 formation, increasing CAV-3 and CCK-1R sequestration in the caveolae and impairing CCK-8-induced contraction. CAV-3 siRNA reduced CAV-3 protein expression, decreased CCK-8-induced contraction, and accumulated CCK-1R in the caveolae. Abnormal concentrations of caveolar cholesterol had no effect on met-enkephalin that stimulates a delta-opioid receptor that internalizes through clathrin. We found that impaired muscle contraction in GBs with cholesterol stones is due to high caveolar levels of cholesterol that inhibits pCAV-3 generation. Caveolar cholesterol increases the caveolar sequestration of CAV-3 and CCK-1R caused by their reduced recycling to the PM.
Cong
P
P
Department of Medicine, Rhode Island Hospital, Brown University Medical School, Providence, USA.
Pricolo
V
V
Biancani
P
P
Behar
J
J
D000818:Animals; D051244:Caveolin 3 / Q000235:genetics / Q000378:metabolism*; D002462:Cell Membrane; D002478:Cells, Cultured; D002784:Cholesterol / Q000494:pharmacology*; D019204:GTP-Binding Proteins / Q000378:metabolism; D005704:Gallbladder / Q000033:anatomy & histology*; D005786:Gene Expression Regulation; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D032342:Muscle Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism*; D043886:Receptor, Cholecystokinin A / Q000235:genetics / Q000378:metabolism*; D012844:Sincalide / Q000494:pharmacology
D051244:Caveolin 3; D043886:Receptor, Cholecystokinin A; D002784:Cholesterol; D019204:GTP-Binding Proteins; D012844:Sincalide